title: Comment on published article in Lupus: Autoimmune myelofibrosis with pancytopenia as a presenting manifestation of systemic lupus erythematosus responsive to mycophenolate mofetil; IVIG in myelofibrosis in SLE.
authors.affiliation: 1 Chaim Sheba Medical Center, Zabludowicz Center for Autoimmune Diseases, Tel-Hashomer, Israel.
authors.forename: Y
authors.initials: Y
authors.lastname: Shoenfeld
authors.affiliation: 2 Wolfson Medical Center - Internal Medicine C, Holon, Israel.
authors.forename: G
authors.initials: G
authors.lastname: Zandman-Goddard
authors.affiliation: 3 Meir Medical Center - Internal Medicine W, Kfar-Saba, Israel.
authors.forename: Y
authors.initials: Y
authors.lastname: Levy
mesh_terms: D006801:Humans; D016756:Immunoglobulins, Intravenous; D008180:Lupus Erythematosus, Systemic; D009173:Mycophenolic Acid; D010198:Pancytopenia; D055728:Primary Myelofibrosis
chemical_list: D016756:Immunoglobulins, Intravenous; D009173:Mycophenolic Acid